Research

Adherence

Dispensing rates for GLP-1 RAs are significantly lower for obesity (AOM) indications compared to diabetes (ADM) indications, with a large gap in 60-day initiation rates.

Even if prescribed, GLP-1 RAs for weight loss are less likely to be filled than those for diabetes, largely due to insurance coverage issues. If you are prescribed an AOM GLP-1 RA, proactively check your insurance coverage and explore assistance programs to ensure you can access the medication.

ModerateQualifiesMEDIUM confidence
71.5% of first-time ADM prescriptions overall and 74.9% in September 2023 had a fill within 60 days. By comparison, 45.6% of first-time AOM prescriptions overall and 32.1% in September 2023 had a fill within 60 days.
Samuel Gratzl et al. · medRxiv · 2024

Why this rating

Real-world observational data.

Source

Monitoring Report: GLP-1 RA Prescribing Trends - September 2024 Data

Samuel Gratzl et al. · medRxiv · 2024

DOI 10.1101/2024.01.18.24301500

preprint · n=1063200Cited 18×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →